Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
Clinical trial NCT04355364 · TERMINATED
Trial details
- NCT number
- NCT04355364
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-21
- Primary completion
- 2021-12-20
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.